RUO materials are not subject to FDA pre-market approval for human administration, cannot be used as drug ingredients in compounding, and are not intended for diagnostic, therapeutic, or veterinary use
Unlike synthetic skin treatments that may disrupt natural skin processes, GHK-Cu works in harmony with the bodys innate repair mechanisms
Adult raphe-specific deletion of Lmx1b leads to central serotonin deficiency
This is extremely rare with peptides but requires immediate response - Chest pain or significant heart rate changes after starting a new peptide, especially if you take cardiovascular medications Contact your provider within 24 hours for: - Persistent nausea or vomiting that doesn't resolve within 24 hours of starting a new compound - Injection site reactions that spread, worsen, or show signs of infection (increasing redness, warmth, streaking) - Significant mood changes (anxiety, agitation, depression) after adding a new peptide to your protocol - Unusual swelling, particularly in hands, feet, or face (can indicate fluid retention from GH peptides) Keep your provider's contact information easily accessible
